FDA Adverse Event Injury Summary report: N

BLT Ø2.9MM SC, SLACTIVE® 10MM, RXD, LOXI

MDR report key: 15251731 · Received August 18, 2022

Report

Report Number
0001222315-2022-17259
Event Type
Injury
Date Received
August 18, 2022
Date of Event
July 7, 2022
Report Date
August 18, 2022
Manufacturer
INSTITUT STRAUMANN AG
Product Code
DZE
UDI-DI
07630031728005
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
NH, US
Reporter Occupation
DENTIST
Health Professional
Yes

Narratives

Description of Event or Problem · 0

THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2022 IN ADA 20. DETAILS OF SURGERY: IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE. ON (B)96) 2022, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III, INADEQUATE BONE QUALITY/QUANTITY AND PREVIOUS BONE AUGMENTATION. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS, SWELLING, FISTULA AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2461416 BLT Ø2.9MM SC, SLACTIVE® 10MM, RXD, LOXI ENDOSSEOUS DENTAL IMPLANT DZE INSTITUT STRAUMANN AG SLActive Roxolid BL HGK66 07630031728005

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male Required Intervention